CN1824742A - Method of applying iodophor as eyepiece clearing agent of cavity mirrow operation - Google Patents
Method of applying iodophor as eyepiece clearing agent of cavity mirrow operation Download PDFInfo
- Publication number
- CN1824742A CN1824742A CN 200510020400 CN200510020400A CN1824742A CN 1824742 A CN1824742 A CN 1824742A CN 200510020400 CN200510020400 CN 200510020400 CN 200510020400 A CN200510020400 A CN 200510020400A CN 1824742 A CN1824742 A CN 1824742A
- Authority
- CN
- China
- Prior art keywords
- iodophor
- eyepiece
- ocular head
- iodine
- mirrow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Apparatus For Disinfection Or Sterilisation (AREA)
Abstract
The present invention provides a method capable of using iodophor as cleaning agent for cleaning eyepiece of cavascope operation. Said method is characterized by that after the iodophor solution containing above 0.1% of effective iodine is diluted, said iodophor solution can be used for abrasively cleaning eyepiece so as to make eyepiece attain high distinctness effect in the operation.
Description
Affiliated technical field
The present invention relates to a kind of ocular head that Surgidine is used for endoscope-assistant surgery method clearly that contains.
Background technology
Chamber mirror minimal invasive techniques in the medical science is carried out for many years; research causes in the fog filter method because of the abdominal cavity temperature difference; how to protect expensive precision instrument ocular head; prolong the scope life-span; the non-stimulated no intercurrent disease of patient is taken place; and can guarantee to give at any time the high-resolution visual field in the operation, and in clinical, solve difference variation fog filter problem in the operation, all do not obtain promising result at present in the world.
Traditional antifog ocular head method has following several at present: 1, soak ocular head with 60-70 degree stroke-physiological saline solution Celsius, reach the antifog purpose of heating, (2002 the 8th the 12nd phases of volume of " Modern Nursing " magazine, the 925th page).This shortcoming of heating the ocular head method is, easily makes eyepiece wear out, break, and particularly the eyepiece that re-uses after the maintenance forbids to use this method, and expensive precision instrument should not add in the hot water in the water neutralization and soaks.2, use spray-proof oil, (the 39th the 10th phase of volume of " Chinese nursing magazine " October in 2004, the 761st page), the shortcoming of this spray-proof oil is, costs an arm and a leg, and takes easy pollution repeatedly, the sterilization difficulty, and clear effect is also undesirable.3, the automatic mist elimination of electronics system, (" Chinese nursing magazine " October in 2004 the 39th volume, the 10th phase, the 761st page), the method for this automatic mist elimination makes still that the visual field does not reach the high-resolution effect in the art.
Summary of the invention
The objective of the invention is to,, make the clinical effectiveness of any ocular head visual field high-resolution in surgical procedure with a kind of simple, sharpness that method that cost is low increases ocular head.
The contriver finds, the Iodophor after the dilution can be used for the clear and antifog of employed ocular head in the mirror Minimally Invasive Surgery of chamber.The title of Iodophor in pharmacopeia is Iodophors and chelated iodine again povidone iodine, is the indefinite form complex compound of iodine and tensio-active agent, and tensio-active agent plays carrier and hydrotropy effect, because Iodophor is a class mixture, so no certain molecular formula and molecular weight.Be present unique being recorded into American Pharmacopeia, British Pharmacopoeia, the sterilized product of the Japanese Pharmacopoeia and the Pharmacopoeia of the People's Republic of China, 9 years again by in the income national essential drugs catalogue, and goes through to can be used on the disinfectant that health care, human body are directly used.So up to now, Iodophor all is to be used to broad-spectrum disinfection-sterilization.
Realize that method of the present invention is: will effectively contain the iodophor solution dilution of iodine more than 0.1%, clean ocular head, and can make ocular head in endoscope-assistant surgery, reach the high-resolution effect with the iodophor solution after the dilution, and can be because of difference variation fog filter in the chamber; The concentration of described iodophor solution dilution is for containing available iodine 0.02-0.1%.
The invention has the advantages that: overcome traditional defogging method capable and cost an arm and a leg, the sterilization difficulty is damaged instrument, the shortcoming of clear poor effect.Iodophor is used for endoscope-assistant surgery ocular head mist elimination, and the sharpness height is better than traditional defogging method capable, and easy and simple to handle, with low cost.Because Iodophor itself just has the character of sterilization, the iodophor solution pungency that is diluted to below 0.1% is little, clinical application, and patient does not have complication, just has the effect of sterilization so Iodophor is used for ocular head mist elimination itself.
Embodiment 1, with " day letter board " disinfectant tamed iodine that Sichuan China day Scientific and Technical Industry Co., Ltd produces, its effective amount of iodine is 0.5% stoste, adding water for injection, to be diluted to effective amount of iodine be 0.02% iodophor solution.With wiping ocular head behind the iodophor solution of cotton fibre or husky cloth infiltration 0.02%, can make ocular head in endoscope-assistant surgery, reach the high-resolution effect, and can be because of difference variation fog filter in the chamber.
Embodiment 2, with " day letter board " disinfectant tamed iodine that Sichuan China day Scientific and Technical Industry Co., Ltd produces, its effective amount of iodine is 0.5% stoste, adding water for injection, to be diluted to effective amount of iodine be 0.05% iodophor solution.With wiping ocular head behind the iodophor solution of cotton fibre or husky cloth infiltration 0.05%, can make ocular head in endoscope-assistant surgery, reach the high-resolution effect, and can be because of difference variation fog filter in the chamber.
Embodiment 3, with " day letter board " disinfectant tamed iodine that Sichuan China day Scientific and Technical Industry Co., Ltd produces, its effective amount of iodine is 0.5% stoste, adding water for injection, to be diluted to effective amount of iodine be 0.1% iodophor solution.With wiping ocular head behind the iodophor solution of cotton fibre or husky cloth infiltration 0.1%, can make ocular head in endoscope-assistant surgery, reach the high-resolution effect, and can be because of difference variation fog filter in the chamber.
Claims (2)
1, uses the method for Iodophor, it is characterized in that: will contain the iodophor solution dilution of available iodine more than 0.1%, and clean ocular head, and be used for the clear and antifog of ocular head with the iodophor solution after the dilution as clear dose of the ocular head of endoscope-assistant surgery.
2, application Iodophor according to claim 1 is characterized in that as the method for clear dose of the ocular head of endoscope-assistant surgery: will contain the iodophor solution of available iodine more than 0.1% and be diluted to the iodophor solution that contains available iodine 0.02-0.1%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510020400 CN1824742A (en) | 2005-02-22 | 2005-02-22 | Method of applying iodophor as eyepiece clearing agent of cavity mirrow operation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510020400 CN1824742A (en) | 2005-02-22 | 2005-02-22 | Method of applying iodophor as eyepiece clearing agent of cavity mirrow operation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1824742A true CN1824742A (en) | 2006-08-30 |
Family
ID=36935584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510020400 Pending CN1824742A (en) | 2005-02-22 | 2005-02-22 | Method of applying iodophor as eyepiece clearing agent of cavity mirrow operation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1824742A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111196917A (en) * | 2018-11-20 | 2020-05-26 | 臧唯 | Visual field clarifying agent for endoscope |
-
2005
- 2005-02-22 CN CN 200510020400 patent/CN1824742A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111196917A (en) * | 2018-11-20 | 2020-05-26 | 臧唯 | Visual field clarifying agent for endoscope |
| CN111196917B (en) * | 2018-11-20 | 2022-10-14 | 臧唯 | Visual field clarifying agent for endoscope |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009004362A (en) | Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through glk. | |
| CN111718687B (en) | Medical mirror anti-fog liquid and preparation method thereof, medical mirror anti-fog film and preparation method thereof, anti-fog method and medical instrument | |
| CN1824742A (en) | Method of applying iodophor as eyepiece clearing agent of cavity mirrow operation | |
| Mendonca-Caridad et al. | Synovial chondromatosis of the temporomandibular joint: arthroscopic diagnosis and treatment of a case | |
| Spinner et al. | Fractures of the supracondylar process of the humerus | |
| RU2007129571A (en) | COMPOSITIONS BASED ON SALTS OF HYALURONIC ACID FOR THE TREATMENT OF EPITELIAL INJURIES | |
| IT1306643B1 (en) | PROCESS FOR THE PREPARATION OF SELF-CROSS-LINKED COMPOUNDS OF Hyaluronic Acid and ITS DERIVATIVES OBTAINABLE BY TECHNIQUE | |
| Committee et al. | Endoscopic tattooingFebruary 2002 | |
| CN112870455B (en) | Gel preparation containing hyaluronic acid, preparation method and application thereof in endoscopy | |
| WO2001018031A3 (en) | Peptides and pharmaceutical compositions comprising same | |
| JP2010013384A (en) | High molecular weight sericin aqueous solution | |
| CN112094317A (en) | His-Gly-Lys modified methotrexate, synthesis, anti-transfer activity and application thereof | |
| EP3389734B1 (en) | Self-assembling peptides comprising non-ionic polar amino acids for anti-adhesion | |
| CN107349189B (en) | A kind of sorbierite mannitol flushing liquor suitable for urological surgery | |
| NO20034453D0 (en) | Use of CD25-binding molecules in steroid-resistant patients | |
| CN209091311U (en) | Antifog sponge structure | |
| DE50012052D1 (en) | USE OF OIL-IN-WATER EMULSION FOR THE MANUFACTURE OF A MEDICAMENT | |
| JPH02138129A (en) | Lubricant | |
| CA1217425A (en) | Oxytetracyclin-solutions | |
| Xu et al. | Transtubular evacuation of hypertensive intracerebral hemorrhage with limited equipment | |
| CN102580104A (en) | Narcotic drug composition for examining or curing cavities and preparation method of narcotic drug | |
| CN1626164A (en) | Gel for local anesthesia and analgesia on surface of skin, and usage | |
| Rao | QRS for BDS 4th Year-E-Book: Oral and Maxillofacial Surgery | |
| RU2003346C1 (en) | Composition for enzymic hydrolysis of protein | |
| Li et al. | New Technology in the Treatment of Maxillary Sinus Cysts. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |